mouse astrocyte-derived pluripotent stem cell therapy (University of Nebraska Medical Center)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namemouse astrocyte-derived pluripotent stem cell therapy (University of Nebraska Medical Center)
Drug Alias NameAsiPS cell therapy (University of Nebraska Medical Center)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Nebraska Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Nebraska Medical Center
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A